Cost Per Responder of Apremilast Versus Infliximab Biosimilar, Etanercept, Adalimumab, Ustekinumab and Secukinumab in Patients with Moderate to Severe Psoriasis in Spain
Martinez-Sesmero, JM; Schoendorff, C; Caloto, T
- 期刊名称Value in Health
- 作者Martinez-Sesmero, JM; Schoendorff, C; Caloto, T
- 卷第19卷
- 期第7期
- 印刷ISSN1098-3015
- 文件大小77.73KB
- 发表时间2016-11
- DOI10.1016/j.jval.2016.09.1285